Student-Faculty Publications
PUBLICATIONS
(bold = CCB student, faculty, staff, and alumni)听
2026
Becker, K.N., Hagood, M., Creeden, J.F., Heck, H., Haak, P.T., Larder, C., Tipton, C., Schroeder, J. and Eisenmann K.M. (February 18, 2026) Baseline Clinician Attitudes and Practices Regarding Long-Term Neurological Follow-Up for COVID-19 Patients: Early Pandemic Insights With Contemporary Relevance. Cureus 18(2): e103837. DOI 10.7759/cureus.103837
Reddy, MVSSRR, Wood, JF., Norris, J, Becker, K, Murphy, SC, Doddi, S, Imami, A, Ryan, WG, Nguyen, J, Schroeder, J, Eisenmann, K, McCullumsmith, RE (2026) Integrative transcriptomic and perturbagen analyses reveal sex-specific molecular signatures across glioma subtypes. Cancers 18:52. https://doi.org/10.3390/cancers18010052
2025
Becker, K.N., Hagood, M.C., Stuckert, M., Heck, H., Pettee, K., Schroeder, J., Eisenmann, K.M. (2025)Targeting glioblastoma invasion and therapy resistance: Emerging trends and molecular pathways. Tumor Discov. 4:8578.
Ghai, S., Shrestha, R., Su, K-H. (2025) HSF1 at the crossroads of chemoresistance: from current insights to future horizons in cell death mechanisms.听Front Cell Dev Biol. 12:1500880.
Luo, Y., Biswas, H., Makinwa, Y., Liu, SH., Dong, Z., Liu, JY., Zhang, JT., Zou, Y. (2025) A PP2A-mtATR-tBid axis links DNA damage-induced CIP2A degradation to apoptotic dormancy and therapeutic resistance in PDAC. Cancer Lett. 627:217790.
Schwarz, G., Ren, X., Xie, W., Guo, H., Jiang, Y. and Zhang, J. (2025) Engineered exosomes: a promising drug delivery platform with therapeutic potential. Front. Mol. Biosci. 12:1583992.
Sharma, V., Fernando, V., Zheng, X., Choi, E-S., Sweef, O., Thomas, V., Szpendyk, J., Furuta, S. (2025) Immunogenic shift of arginine metabolism triggers systemic metabolic and immulological reprogramming to suppress HER2+ breast cancer.听Cancer Metab. 13:15.
2024
Barlow, L., Josephraj, S., Gu, B., Dong, Z., Zhang, JT. (2024) FASN negatively regulates the expression of p65 by diminishing its stability through phosphorylation at Thr254 and isomerization by Pin1. J Lipid Res. 65:100529.
Creeden, J.F., Sevier, J., Zhang, J.T., Lapitsky, Y., Brunicardi, F.C., Jin, G., Nemunaitis, J., Liu, JY., Kalinoski, A., Rao, D., Liu, SH. (2024) Smart exosomes enhance PDAC targeted therapy. J Control Release听368:413-429.
Dreier, M.R., Walia, J., de la Serna, I.L. (2024) Targeting SWI/SNF Complexes in Cancer: An Overview of Pharmacological Strategies and Consequences. Epigenomes. 2024 8:7.
Fernando, V., Zheng, X., Sharma, V., Sweef, O., Choi, E-S., and Furuta, S. (2024) Reprogramming of Breast Tumor-Associated Macrophages with Modulation of Arginine Metabolism. Life Sci Alliance 7:e202302339.
Letson, J., Ren, G., Zheng, X., Sweef, O., Corcino, Y.L.,听Furuta, S.听Reduced S-nitrosylation of TGF尾1 elevates its binding affinity toward the receptor and promotes fibrogenic signaling in the breast.听J Biol Chem. 2024 Dec;300(12):108011.
Liu, R., Zhao, Y., Su, S., Kwabil, A., Njoku, P.C., Yu, H., Li, X.听 (2024) Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces.听Cancer Lett. 591:216899.
Makinwa, Y., Luo, Y., Musich, P.R., Zou, Y. (2024) Canonical and noncanonical functions of the BH3 domain protein bid in apoptosis, oncogenesis, cancer therapeutics, and aging. Cancers 16:2199.
2023
Ahmad, N., de la Serna, I.L., Marathe, H.G., Fan, X., Dube, P., Zhang, S., Haller, S.T., Kennedy, D.J., Pestov, N.B., and Modyanov, N.N. (2023) Eutherian-specific functions of BetaM acquired through Atp1b4 gene co-option in the regulation of MyoD expression.
Argueta, C.E., Figy, C., Bouali, S., Guo, A., Yeung, K.C., Fenteany, G. (2023) RKIP localizes to the nucleus through a bipartite nuclear localization signal and interaction with importin 伪 to regulate mitotic progression.听 J. Biol. Chem. 299:103023.听
Basuroy, T., Dreier, M., Baum, C., Blomquist, T., Trumbly, R., Filipp, F.V., de la Serna, I.L. (2023) Epidgentic and pharmacological control of pigmentatin via Bromodomain Protein 9 (BRD9).听Pigment Cell Melanoma Res. 36:19-32.
Beamer, M.A., Zamora, C., Nestor-Kalinoski, A.L., Fernando, V., Sharma, V., and Furuta, S. (2023) Novel 3D flipwell system that models gut mucosal microenvironment for studying interactions between gut microbiota, epithelia and immunity. Sci .Rep. 13:870.
Biswas H, Makinwa Y, Zou Y. (2023) Novel cellular functions of ATR for therapeutic targeting:听 Embryogenesis to tumorigenesis. Int J Mol Sci. Jul20;24(14).
Cui, T, Huang, C, Liu J-Y and Zhang J-T (2023) Small molecule inhibitors targeting the "undruggable" survivin: The past, present, and future from a medicinal chemist's perspective. 听J Med Chem 66(24): 16515-16545.
Figy, C.,听Guo, A., Fernando, V.R., Furuta, S., Al-Mulla, F. , Yeung, K. (2023) Changes in expression of tumor suppressor gene RKIP impact how cancers interact with their complex environment. Cancers听 (Basel) 15:958. 听
Ghai, S., Young, A., and Su, K-H. (2023) Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1.听 Front. Cardiovasc. Med. 10:1155444,
Gurung, D., Danielson, J.A., Tasnim, A., Zhang, J.T., Zou, Y., Liu, J.Y. (2023) Proline isomerization: From the chemistry and biology to therapeutic opportunities. Biology (Basel) 12(7).
Heck, H., Tipton, C. Becker, K., Creeden, J., Schroeder, J., Larder, C., Haak, P., Pyles, B., Eisenmann, K. (2023) Impact of COVID-19 on clinical productivity at the University of Toledo Medical Center Specialty Care Clinics. Translation The University of Toledo Journal of Medical Sciences, 11(2). doi:10.46570
Fernando, V., Zheng, X., Sharma, V., Furuta, S. (2023) Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism.听Preprint. bioRxiv. 2023;2023.08.22.554238. Published 2023 Aug 22.
Letson, J., Furuta, S. (2023) Reduced S-nitrosylation of TGF尾1 elevates its binding affinity towards the receptor and promotes fibrogenic signaling in the breast. bioRxiv, 2023 Sep 12:2023.09.07.556714. doi:听https://doi.org/10.1101/2023.09.07.556714
Qin, L., Dong, Z., Huang, C., Liu, H., Beebe, J., Subramaniyan, B., Hao, Y., Liu, Y., He, Z., Liu, J-Y., Zhang, J-T. (2023) Reversible promoter demethylation of PDGFD confers gemcitabine resistance through STAT3 activation and RRM1 upregulation. C听
Raman, D., Cimpean, A.M., and De Miglio, M.R. (2023) Editorial: Drug resistance in breast cancer - mechanisms and approaches to overcome chemoresistance. Front Oncol. 12:1080684.
Zajac, K.K., Malla, S., Babu, R.J.,听Raman, D., Tiwari, A.K. (2023) 听Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.听Cancer Rep (Hoboken). 2023:e1779.